<DOC>
	<DOCNO>NCT02262624</DOCNO>
	<brief_summary>To establish bioequivalence 80 mg telmisartan/12.5 mg HCTZ fix dose combination vs. monocomponents</brief_summary>
	<brief_title>Bioequivalence Telmisartan / HCTZ Fixed Dose Combination Compared Its Monocomponents Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>1 . Healthy male accord follow criterion : Based upon complete medical history , physical finding , physical examination ( measurement height body weight ) , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead ECG ( electrocardiogram ) , clinical laboratory test 1 ) No find clinical relevance 2 ) No evidence clinically relevant concomitant disease 2 . Age ≥ 20 year age ≤ 35 year 3 . Body Mass Index ( BMI ) ≥ 17.6 kg/m2 BMI ≤ 25.0 kg/m2 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) ( MHW Ordinance No . 28 , Mar . 27 , 1997 ) local legislation 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Surgery gastrointestinal tract ( except appendectomy ) 3 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 4 . History relevant orthostatic hypotension , faint spell blackouts 5 . Chronic relevant acute infection 6 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 7 . Positive result Hepatitis B virus surface antigen ( HBsAg ) , anti HCV ( Hepatitis C virus ) , syphilitic test Human immunodeficiency virus ( HIV ) antigenantibody test 8 . Intake drug long halflife ( ≥ 24 hour ) within least 1 month prior administration within period 10 less halflives respective drug trial 9 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial . 10 . Participation another trial investigational drug within 4 month prior administration trial 11 . Smoker ( 20 cigarettes/day ) 12 . Inability refrain smoke hospitalisation 13 . Alcohol abuse ( 60 g ethanol/day : ex . 3 middlesized bottle beer , 3 gous ( equivalent 540 mL ) sake ) 14 . Drug abuse 15 . Blood donation ( 100 mL within four week prior administration trial ) 16 . Excessive physical activity ( within one week prior administration trial ) 17 . Any laboratory value outside reference range clinical relevance 18 . Inability comply dietary regimen study centre 19 . Any volunteer , investigator sub investigator would allow participate study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>